METOPROLOL IV VIATRIS is used to treat an irregular heartbeat, also known as arrhythmia, which means that there is a disturbance of the heart's normal rhythm or beat.

For patients with ST-segment-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention within six hours of symptom onset, the early administration of ...

Patients randomized to metoprolol received at least 1 5-mg IV bolus (82% and 67% received 2 and 3 5-mg boluses, respectively). All patients, except for those who developed contraindications, received ...

Metoprolol tartrate and metoprolol succinate are different salt forms of metoprolol. ... One full dose of the intravenous injection provides 15 mg of the drug.

Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: Randomised placebo-controlled trial. Lancet 2005 Nov 5; 366:1622-32.

Metoprolol, a beta-1 adrenergic receptor antagonist, ... Patients with acute myocardial infarction (AMI) were randomized to receive intravenous (IV) metoprolol 15mg or control pre-reperfusion.

Metoprolol is also available as an intravenous injection. Drug Name : Metoprolol Metoprolol is a beta-blocker, prescribed for high blood pressure either alone or with other medications.

Metoprolol, but not atenolol, is broken down by a liver enzyme called cytochrome P450 2D6. Other medications that interact with this enzyme can alter the levels of metoprolol.

In a pilot trial, intravenous metoprolol given to patients with acute respiratory distress syndrome brought on by COVID-19 was safe, reduced lung inflammation, and improved oxygenation.